Due to the upregulation of CX3CL1 in the CSF and brain of MS patients compared to healthy controls, the authors speculate that the recruitment of highly inflammatory T-cells mediated by CX3CL1 occurs in the brains of MS patients. The gene discussed is CX3CL1; the disease is myeloid sarcoma.